Called Velo, the system can perform true PCR testing in 10 minutes or less and is intended for use in decentralized spaces.

A new study found that women who received mail-in self-collection kits participated in screening at much higher rates than those who just received a telephone reminder.

The firm is maintaining its full-year guidance and expects to make the acquisition once Lex Diagnostics obtains 510(k) clearance of its system.

The RiskReveal assay was used to determine which early-stage non-squamous NSCLC patients should undergo adjuvant chemotherapy ...

The researchers reported in Nature Communications that the PCR-based test and bedside instrument can identify the risk of sepsis within 24 hours.

The BLIPI test device was used to monitor babies' immune status from a drop of whole blood and detected sepsis within 15 minutes, enabling incubator-side testing.

NEW YORK – Danaher subsidiary Cepheid announced Wednesday that its Xpert HIV-1 Viral Load XC assay has received a medical device license from Health Canada. The next-generation extended coverage test ...

The partners will work together to explore the use of a technology from Fujirebio subsidiary Fluxus in infectious disease.

The Randox ConcizuTrace ELISA is used to determine the concentration in blood of Novo Nordisk's Alhemo (concizumab-mtci) to aid dose adjustments.

CHICAGO – A team of researchers from Memorial Sloan Kettering Cancer Center has developed a Pap-based assay for endometrial cancer that is able to detect higher amounts of cell-free DNA than blood ...

NEW YORK – QuidelOrtho announced after the close of the market on Tuesday that it will discontinue development of its Savanna molecular diagnostic system and that it aims to acquire UK-based Lex ...

Company officials disclosed that it had been eyeing an out from Savanna in the potential acquisition of Lex Diagnostics for at least the past 18 months.